Copyright
©The Author(s) 2019.
World J Gastrointest Oncol. Oct 15, 2019; 11(10): 887-897
Published online Oct 15, 2019. doi: 10.4251/wjgo.v11.i10.887
Published online Oct 15, 2019. doi: 10.4251/wjgo.v11.i10.887
Figure 2 Diagnostic accuracy of acylcarnitine for the early diagnosis of hepatocellular carcinoma in non-steatohepatitis patients.
ROC analysis of acylcarnitine revealed that the cutoff value was 5.088, the specificity was 89.5%, the sensitivity was 92.9%, and the AUC was 0.925.
- Citation: Takaya H, Namisaki T, Kitade M, Shimozato N, Kaji K, Tsuji Y, Nakanishi K, Noguchi R, Fujinaga Y, Sawada Y, Saikawa S, Sato S, Kawaratani H, Moriya K, Akahane T, Yoshiji H. Acylcarnitine: Useful biomarker for early diagnosis of hepatocellular carcinoma in non-steatohepatitis patients. World J Gastrointest Oncol 2019; 11(10): 887-897
- URL: https://www.wjgnet.com/1948-5204/full/v11/i10/887.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v11.i10.887